The toxicity profiles of EGFR-TKIs and combination treatments differed from the profiles of traditional chemotherapy treatments as there was an increased prevalence of reports of untoward medical occurrences, including rashes, diarrhea, stomatitis, and interstitial lung disease associated with the former (Supplementary Figure S5). Here, EGFR is linked to interstitial lung disease.